Natco launches drug for blood cancer
Natco Pharma Ltd has announced the launch of its drug for multiple myeloma (a form of blood cancer) under the brand 'Alphalan' (Melphalan) in 2 mg and 5 mg tablet forms. In a press release, the
Natco Pharma Ltd has announced the launch of its drug for multiple myeloma (a form of blood cancer) under the brand 'Alphalan' (Melphalan) in 2 mg and 5 mg tablet forms. In a press release, the